The major international liver societies have published guidelines on surveillance for HCC in individuals with chronic HBV (Table 1) that incorporate 6-monthly ultrasound with or without alpha-fetoprotein (AFP) measurement. The gene discussed is AFP; the disease is hepatocellular carcinoma.